PRLD
Prelude Therapeutics Incorporated
$1.26
$0.00(0.00%)
51
Overall
60
Value
66
Tech
28
Quality
Market Cap
$81.50M
Volume
84.90K
52W Range
$0.61 - $2.01
Target Price
$3.50
Key Metrics Overview
| Market Cap | $81.50M | P/E Ratio | N/A |
| 52W High | $2.01 | 52W Low | $0.61 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 11.6% | 52W Position | 46.4% |
| Overall Score | 51 | Value Score | 60 |
| Quality Score | 28 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-1.55 | EPS Next Est | $-1.23 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $1.26 | 0% | 84.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW